Citations

Showing 10 of 108162 citations.

Managing the tension: From innovation to application in health professions education
Tekian, Ara , Harden, Ronald M. , Cook, David A. , Hunt, Daniel, Norcini, John J. , Steinert, Yvonne

Mayo Clinic

Medical Teacher | November 15, 2019 | Volume: 42 | Issue: 3 | Pages: 333-339

10.1080/0142159x.2019.1687871 | PMID 31726877 Get It

Stem-cell transplantation in multiple myeloma: how far have we come?
Soekojo, Cinnie Yentia , Kumar, Shaji , Soekojo, Cinnie Y , Kumar, Shaji K

Mayo Clinic

Therapeutic Advances in Hematology | November 15, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2040620719888111 | PMID 31798820 Get It

High-dose therapy (HDT) and autologous stem-cell transplantation (ASCT) has historically been an essential part of multiple myeloma (MM) management since early studies demonstrated its efficacy in relapsed disease, and subsequent phase III trials demonstrated better responses and improved survival with this modality compared with standard chemotherapy. With further advances in the MM treatment landscape, including the development of potent novel agents, there has been an increasing debate around various aspects of ASCT, including the optimal timing, role of single versus tandem ASCT, and the practice of consolidation and maintenance therapy post-ASCT. Routine incorporation of the novel agents at each of the treatment phases, induction, consolidation when used, and maintenance has led to better responses as reflected by increasing rates of minimal residual disease (MRD) negativity, longer progression-free survival (PFS) with improvement in overall survival (OS) and in some of the trials. The phase III trials over the last decade have provided significant clarity on the current approach, and have raised important questions regarding the applicability of this modality in all patients. This review aims to summarize the latest literature in the field and discusses how these findings impact the practice of ASCT today.
Patient portal message characteristics and reported thoughts of self-harm and suicide: A retrospective cohort study
Duvall, Michelle J., North, Frederick , Leasure, William B. , Pecina, Jennifer L. , Duvall, Michelle , Leasure, William, Pecina, Jennifer

Mayo Clinic

Journal of Telemedicine and Telecare | November 15, 2019 | Volume: 27 | Issue: 8 | Pages: 501-508

10.1177/1357633x19887262 | PMID 31726902 Get It

Introduction As use of electronic portal communication with healthcare teams increases, processes that effectively recognize messages that contain critical information are needed. This study aims to evaluate whether certain language and other characteristics of patient portal messages are associated with expressions of self-harm and suicidal ideation. Methods Using patient portal messages sent between 1 January 2013 and 30 June 2017, we searched for words and letter combinations ‘suicid’ (to identify words suicide and suicidal), ‘depress’ (for depression, depressed, depressing), ‘harm himself’ (or ‘herself ‘or ‘myself’), ‘hurt himself’ (‘herself’ or ‘myself’), ‘kill’, ‘shoot’, ‘cutting’, ‘knife’, ‘gun’, ‘overdose’, ‘over dose’ and ‘jump’. Results Of 831,009 messages, 11,174 messages contained one or more search terms. We manually reviewed 7,736 messages for content expressing self-harm or suicidality. Of the reviewed messages, 3.2% indicated thoughts of self-harm or suicide and 2.2% of messages suggested active suicidality. Of those expressing any thoughts of self-harm or suicide, 13.4% mentioned a specific plan, 20% were passively suicidal. Messages indicating thoughts of self-harm and suicide were more common in patients who were unmarried, non-white and younger than 18 years. Factors significantly associated with thoughts of self-harm were messages addressed to psychiatry or containing the letter combinations ‘suicide’, ‘die’, ‘depress’ and ‘harm/hurt my/her/himself’. Discussion Certain letter combinations and patient portal message characteristics may be associated with expressions of self-harm and suicide. These factors should be considered as we develop systems of effectively screening patient portal messages for critical clinical information.
Neutrophil Extracellular Traps and Liver Disease
Hilscher, Moira , Shah, Vijay H. , Hilscher, Moira B

Mayo Clinic

Seminars in Liver Disease | November 15, 2019 | Volume: 40 | Issue: 02 | Pages: 171-179

10.1055/s-0039-3399562 | PMID 31726473 Get It

AbstractNeutrophil extracellular traps, or NETs, are heterogenous, filamentous structures which consist of extracellular DNA, granular proteins, and histones. NETs are extruded by a neutrophil in response to various stimuli. Although NETs were initially implicated in immune defense, subsequent studies have implicated NETs in a spectrum of disease processes, including autoimmune disease, thrombosis, and cancer. NETs also contribute to the pathogenesis of several common liver diseases, including alcohol-associated liver disease and portal hypertension. Although there is much interest in the therapeutic potential of NET inhibition, future clinical applications must be balanced against potential increased risk of infection.
Role of CD4+ CD25+ FOXP3+ regulatory T-cells and human papilloma virus infection in Egyptian Women with breast cancer
Tawfeik, Amany M , Mora, Ahmed , Osman, Ahmed , El-Sheikh, Nabila, Elrefaei, Mohamed

Mayo Clinic

No container title available | November 14, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.17376/v1 Get It

Abstract Several subsets of regulatory CD4+ T cells (CD4+ Tregs) have been described in peripheral blood and tumor microenvironment and blood of breast cancer (BC) patients and may play a key role in the progression of BC. High-risk human papilloma virus (HPV) have a causal role in a significant proportion of cervical, and head, and neck tumors and may play an important role in evoking neoplasia in BC. In this study we assessed the prevalence of CD4+Tregs (CD4+CD25+ FOXP3+ cells) and CD8+T cells by flow cytometry in peripheral blood from a total of 55 Egyptian women, including 20 treatment-naïve BC, 15 with breast benign lesions (BBL) and 20 healthy volunteers (HV). High-risk HPV genotype type 16, 18, and 31 was investigated in breast tissue from all BC and BBL patients using Real-Time PCR. HPV was detected in 4 BC, but in none of BBL patients. The frequency of CD4+ Tregs was significantly higher in BC compared to BBL and HV, (p < 0.001). In addition, we observed a significantly higher frequency of CD8+ T cells in peripheral blood of patients with late stage III compared to early stage I and II BC (p = 0.011). However, there was no significant association between the ratio of CD8+ T cell to CD4+ Tregs frequencies and the expression of Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2). In conclusion, CD4+ Tregs may contribute to progression BC in Egyptian women with HPV infection. The potential role CD4+ Tregs as a prognostic or predictive parameter should be analyzed in a larger longitudinal study with sufficient follow-up time.
Severe Community-Acquired Pneumonia in Eastern China Microbial Etiology and Multidrug-Resistance
Wang, Yuli , Ni, Xiaoying , Huang, Shenglei, Jia, Ping, Yang, Ping , Zhu, Lei, She, Jun , Jia, Ping

Mayo Clinic

No container title available | November 14, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.16835/v1 Get It

Abstract Background: Limited information existed about the distributions of microbial etiology and drug-resistance with severe community-acquired pneumonia (CAP) in China, partly attributing to the antibiotics abuse in rearing livestock for Chinese farmers in recent decades. Moreover, the relevant guidelines have not been updated for at least a decade.Methods: A prospective observational study was carried out in Zhongshan Hospital (Shanghai, China). All consecutive cases of severe CAP diagnosed in Respiratory intensive care unit (ICU) and Emergency ICU were included. We assessed the microbial etiology features and multidrug-resistance (MDR) status. The risk factors were used by multivariate analyses for outcomes.Results: One hundred and twelve adults with severe CAP in ICUs, mean age of 65.7±15.1 years were studied. Etiological diagnoses were established in 76 (67.9%) cases; Klebsiella pneumoniae was the most frequent pathogen in 27 (35.5%) cases followed by Acinetobacter baumannii (n=15, 19.7%) and Methicillin-resistant Staphylococcus aureus (MRSA) (n=9, 11.8%); While Streptococcus pneumoniae (n=3, 3.9%) was ranked the 6 th in the study. The majority of pathogens were the MDR and the 30-days mortality rate was 43.8% in severe CAP patients. Klebsiella pneumoniae (OR, 6.88; 95%CI, 1.13-41.83), Sequential organ failure assessment (SOFA)≥5(OR, 12.30; 95%CI, 1.79-84.55) was associated to death.Conclusions: The study indicates a change in the usual pattern of microbiol etiology of severe CAP and the MDR emerged in the majority of pathogens over a decade in eastern China. Enhanced control of using antibiotics to reduce the acquired resistance is urgent.
Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement
Rosen, Ilene M. , Aurora, R. Nisha , Kirsch, Douglas B. , Carden, Kelly A., Malhotra, Raman K. , Ramar, Kannan , Abbasi-Feinberg, Fariha, Kristo, David A., Olson, Eric J. , Rosen, Carol L. , Rowley, James A. , Shelgikar, Anita V., Martin, Jennifer L.

Mayo Clinic

Journal of Clinical Sleep Medicine | November 14, 2019 | Volume: 15 | Issue: 11 | Pages: 1671-1673

10.5664/jcsm.8062 | PMID 31739858 Get It

Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing
Nokes, Brandon , Raza, Hassan , Cartin‐Ceba, Rodrigo , Lyng, Phillip J., Krahn, Lois E., Wesselius, Lewis , Jokerst, Clinton, Umar, Sarah B. , Griffing, W. Leroy , Neville, Matthew R., Parish, James M., Raza, Hassan A, Lyng, Philip J., Malhotra, Atul

Mayo Clinic

Journal of Clinical Sleep Medicine | November 14, 2019 | Volume: 15 | Issue: 11 | Pages: 1665-1669

10.5664/jcsm.8036 | PMID 31739857 Get It

Epidemiology of Liver Cancer in Africa: Current and Future Trends
Okeke, Edith, Davwar, Pantong , Roberts, Lewis R. , Sartorius, Kurt , Spearman, W., Malu, Abraham O., Duguru, Mary, Roberts, Lewis, Roberts, Lewis R

Mayo Clinic

Seminars in Liver Disease | November 14, 2019 | Volume: 40 | Issue: 02 | Pages: 111-123

10.1055/s-0039-3399566 | PMID 31726474 Get It

Abstract Hepatocellular carcinoma (HCC) is a disease of global public health significance with mortality on the rise, despite the preventable nature of its risk factors especially in Africa. It is now the sixth most common cancer worldwide, fifth in males, and ninth in females. HCC incidence and mortality are predicted to increase in African countries constrained by limited resources to combat endemic levels of viral infection and synergistic environmental risk factors. The changing nature of HCC etiology is particularly illustrated here with the traditional risk factors like viral hepatitis coexisting alongside high human immunodeficiency virus (HIV) prevalence and rapidly increasing urbanization that have promoted a sharp increase in additional risk factors like coinfection, type 2 diabetes mellitus, and obesity. Although there are some differences in etiology between North Africa and sub-Saharan Africa, risk factors like chronic viral hepatitis B and C, aflatoxin exposure, and iron overload predominate. Aggressive hepatitis B genotypes, combined with hepatitis B virus/hepatitis C virus/HIV coinfections and aflatoxin exposure, promote a more aggressive molecular phenotype. In parallel to a better understanding of the molecular etiology of HCC, policy and planning initiatives to address the burden of HCC must be anchored within the reality of the limited resources available. Establishment and coordination of cancer registries across Africa is needed to improve the quality of data necessary to galvanize action. Preventive measures including hepatitis B vaccination programs, measures to prevent maternal-to-child and child-to-child transmission, delivery of universally accessible antiretroviral and antiviral treatments, and reduction of dietary aflatoxin exposure can contribute markedly to reduce HCC incidence. Finally, the development of biomarkers and new therapeutic interventions will need a better understanding of the unique genetic and epigenetic characteristics of HCC on the continent. We present a narrative review of HCC in Africa, discussing present and future trends.
Optical Coherence Tomography Monitoring in a Patient With Retinoblastoma
Yu, Michael D. , Dalvin, Lauren A. , Shields, Carol L.

Mayo Clinic

JAMA Ophthalmology | November 14, 2019 | Volume: 137 | Issue: 11 | Pages: e186243

10.1001/jamaophthalmol.2018.6243 | PMID 31725840 Get It